Blue Energy Raises $380M in Funding Led by VXI Capital

The round also saw participation from other existing investors, including At One Ventures and Tamarack Global. The company plans to use the funds to buy key equipment, support project development, and cover general business expenses.

Blue Energy is developing prefabricated nuclear power plants that work with leading reactor technologies and can be built in as little as 48 months. Traditional nuclear plant construction is complex and often leads to delays, higher costs, and financing uncertainty, which has limited private investment and increased reliance on public funding. Blue Energy aims to solve these challenges by using a new development approach focused on centralized manufacturing, skilled labor, and more predictable timelines to reduce construction risk.

Blue Energy plans to make nuclear power more reliable and affordable by enabling project financing and building modular plants offsite using proven components, fixed price contracts and clear timelines. The company expects to start construction on its first project in Texas in Q3 2026, aiming to generate up to 1.5 gigawatts of power for large users such as AI data centers.

The US Nuclear Regulatory Commission recently approved Blue Energy’s new construction approach which starts by powering turbines with natural gas before switching to nuclear energy. This marks an important regulatory milestone, and sets a new example for phased nuclear plant construction in the United States.

Read More:Deep Blue Medical Raises $5.6M in Series A Funding

"VXI is proud to partner with Blue Energy as the company unlocks the largest underutilized resource civilization has: nuclear power," said Orin Hoffman, Managing Director of VXI Capital and Board Director at Blue Energy. "By delivering abundant, affordable nuclear power, Blue Energy is perfectly positioned to meet rapidly increasing near-term energy demand from data centers and advanced manufacturing. Our investment reflects our confidence that, by building the world's first project-financed nuclear power plant, Blue Energy will rewrite the playbook for nuclear power's next era."

"The Blue Energy team has made remarkable progress de-risking the single hardest problem in nuclear — the cost structure that makes it project-financeable," said Michael Kearney, General Partner at Engine Ventures and Board Director at Blue Energy. "Their manufacturing and development approach is what finally positions nuclear to run down the cost curve necessary for rapid deployment to meet this moment of demand growth, and we couldn't be more excited to back them on that path."

"This funding marks an important step in Blue Energy's mission to make new nuclear more deployable, predictable, and financeable," said Blue Energy CEO and Co-Founder Jake Jurewicz. Blue Energy is poised to deliver a significantly de-risked product and finally attract the private capital that nuclear deployment has historically struggled to secure. And for the first time, a nuclear project is designed so that it doesn't need to rely primarily on taxpayer dollars and ratepayers to backstop risk.

"By combining offsite prefabrication, standardized plant delivery and a disciplined development model, we believe Blue Energy can reduce cost and compress timelines to make nuclear power competitive with fossil fuel and renewables – all without sacrificing safety. Blue Energy is developing a nuclear power product designed to scale at a time when the world needs it most. "Said Jake Jurewicz."

About Blue Energy

Founded in 2023, by Jake Jurewicz, Blue Energy builds turnkey nuclear power plants that work with leading reactor technologies. The company uses offsite prefabrication and a lower cost financing model to deliver nuclear projects faster, more predictably and more affordably. Its goal is to deliver reliable baseload power that can compete with fossil fuels and renewables to meet growing global energy demand. Blue Energy is backed by a team with strong experience in nuclear construction, licensing, engineering, and project development.

Read More:Ray Therapeutics Raises $125M in Series B Funding